Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy

Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy

Knowledge of clinically targetable tumor antigens is becoming vital for broader design and utility of therapeutic cancer vaccines. This information is obtained reliably by directly interrogating the MHC-I presented peptide ligands, the immunopeptidome, with state-of-the-art mass spectrometry. Our ma...

Full description

Bibliographic Details
Main Authors:	Karita Peltonen, Sara Feola, Husen M. Umer, Jacopo Chiaro, Georgios Mermelekas, Erkko Ylösmäki, Sari Pesonen, Rui M. M. Branca, Janne Lehtiö, Vincenzo Cerullo
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	Cancers
Subjects:	tumor antigen endogenous retrovirus cancer vaccine immunotherapy immunopeptidome ligandome
Online Access:	https://www.mdpi.com/2072-6694/13/14/3408

Similar Items

Uncovering the Tumor Antigen Landscape: What to Know about the Discovery Process
by: Sara Feola, et al.
Published: (2020-06-01)

Mining the Immunopeptidome for Antigenic Peptides in Cancer
by: Ricardo A. León-Letelier, et al.
Published: (2022-10-01)

Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome
by: Scott D. Brown, et al.
Published: (2019-03-01)

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines
by: Sara Feola, et al.
Published: (2022-03-01)

Immunolyser: A web-based computational pipeline for analysing and mining immunopeptidomic data
by: Prithvi Raj Munday, et al.
Published: (2023-01-01)

Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics
by: Marcel Wacker, et al.
Published: (2023-07-01)

Integrated Immunopeptidomic and Proteomic Analysis of COVID-19 lung biopsies
by: Shanye Yin, et al.
Published: (2023-10-01)

Immunopeptidomics toolkit library (IPTK): a python-based modular toolbox for analyzing immunopeptidomics data
by: Hesham ElAbd, et al.
Published: (2021-08-01)

Birinapant Reshapes the Tumor Immunopeptidome and Enhances Antigen Presentation
by: Weiyan Zhang, et al.
Published: (2024-03-01)

Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome
by: Maddalena Marconato, et al.
Published: (2022-09-01)

The Impact of Biomaterial Cell Contact on the Immunopeptidome
by: Michael Ghosh, et al.
Published: (2020-12-01)

Editorial: Immunopeptidomic Approaches for the Identification of Tumor (neo)Antigens
by: Jennie R. Lill, et al.
Published: (2022-05-01)

Deciphering Human Leukocyte Antigen Susceptibility Maps From Immunopeptidomics Characterization in Oncology and Infections
by: Pablo Juanes-Velasco, et al.
Published: (2021-05-01)

Immunopeptidomics in the Era of Single-Cell Proteomics
by: Rupert L. Mayer, et al.
Published: (2023-12-01)

Cloud Computing Based Immunopeptidomics Utilizing Community Curated Variant Libraries Simplifies and Improves Neo-Antigen Discovery in Metastatic Melanoma
by: Amol Prakash, et al.
Published: (2021-07-01)

1,2,3, MHC: a review of mass-spectrometry-based immunopeptidomics methods for relative and absolute quantification of pMHCs
by: L.E. Stopfer, et al.
Published: (2021-10-01)

BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens
by: Maria Virginia Ruiz Cuevas, et al.
Published: (2023-08-01)

SAPrIm, a semi-automated protocol for mid-throughput immunopeptidomics
by: Terry C. C. Lim Kam Sian, et al.
Published: (2023-06-01)

An open-source computational and data resource to analyze digital maps of immunopeptidomes
by: Etienne Caron, et al.
Published: (2015-07-01)

Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome
by: Saghar Kaabinejadian, et al.
Published: (2022-01-01)

The HLA class-II immunopeptidomes of AAV capsids proteins
by: Carlos A. Brito-Sierra, et al.
Published: (2022-12-01)

The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein
by: Michael D. Knierman, et al.
Published: (2020-12-01)

A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma
by: Kirti Pandey, et al.
Published: (2023-08-01)

The Importance of Being Presented: Target Validation by Immunopeptidomics for Epitope-Specific Immunotherapies
by: Jonas P. Becker, et al.
Published: (2022-04-01)

Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome
by: Kevin Michael Boehm, et al.
Published: (2019-01-01)

Is the Immunopeptidome Getting Darker?: A Commentary on the Discussion around Mishto et al., 2019
by: Anthony W. Purcell
Published: (2021-07-01)

Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma
by: Yue A. Qi, et al.
Published: (2021-10-01)

Erratum: The HLA class-II immunopeptidomes of AAV capsids proteins
by: Frontiers Production Office
Published: (2023-07-01)

IntroSpect: Motif-Guided Immunopeptidome Database Building Tool to Improve the Sensitivity of HLA I Binding Peptide Identification by Mass Spectrometry
by: Le Zhang, et al.
Published: (2022-04-01)

Characterising the HLA‐I immunopeptidome of plasma‐derived extracellular vesicles in patients with melanoma
by: Caitlin Boyne, et al.
Published: (2024-03-01)

Borrelia burgdorferi-Induced Changes in the Class II Self-Immunopeptidome Displayed on HLA-DR Molecules Expressed by Dendritic Cells
by: Maria G. Gutierrez-Hoffmann, et al.
Published: (2020-09-01)

Critical Review of Existing MHC I Immunopeptidome Isolation Methods
by: Alexandr Kuznetsov, et al.
Published: (2020-11-01)

COSMIC-based mutation database enhances identification efficiency of HLA-I immunopeptidome
by: Fanghzou Wang, et al.
Published: (2024-02-01)

Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia
by: Annika Nelde, et al.
Published: (2021-07-01)

Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows
by: Thomas Partridge, et al.
Published: (2018-04-01)

Immunopeptidomic Data Integration to Artificial Neural Networks Enhances Protein-Drug Immunogenicity Prediction
by: Carolina Barra, et al.
Published: (2020-06-01)

Tapasin-mediated editing of the MHC I immunopeptidome is epitope specific and dependent on peptide off-rate, abundance, and level of tapasin expression
by: Denise S. M. Boulanger, et al.
Published: (2022-10-01)

Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
by: Markus W. Löffler, et al.
Published: (2019-04-01)

Characterization of CD8+ T-cell responses to non-anchor-type HLA class I neoantigens with single amino-acid substitutions
by: Tomoyo Shinkawa, et al.
Published: (2021-01-01)

HLA-A24 ligandome analysis of colon and lung cancer cells identifies a novel cancer-testis antigen and a neoantigen that elicits specific and strong CTL responses
by: Vitaly Kochin, et al.
Published: (2017-04-01)